Article
Regeneron sees strong initial demand for higher-dose Eylea
Rating:
0.0
Views:
61
Likes:
1
Library:
1
Regeneron Pharmaceuticals on Thursday said it is seeing strong initial demand for its recently launched higher-dose version for eye drug Eylea.
Rate This Post
-
Education
-
Communication
-
Entertainment
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value